Refresh

Dishman Pharmaceuticals & Chemicals Ltd.[Merged] - Research Center

532526 DISHMAN Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 16 Mar ' 15 Mar ' 14 Mar ' 13 Mar ' 12
Income

Operating income

510.39 478.69 473.28 484.64 463.40
Expenses

Material consumed

194.38 199.90 176.07 179.57 195.63

Manufacturing expenses

29.74 31.67 29.47 32.99 25.02

Personnel expenses

65.89 58.88 58.38 58.21 45.22

Selling expenses

- - - - -

Adminstrative expenses

49.60 39.15 33.15 46.32 52.57

Expenses capitalised

- - - - -

Cost of sales

339.61 329.60 297.07 317.09 318.45

Operating profit

170.78 149.09 176.21 167.55 144.96

Other recurring income

62.38 67.00 55.98 13.59 11.77

Adjusted PBDIT

233.16 216.09 232.19 181.14 156.73

Financial expenses

68.66 68.13 69.22 51.10 57.54

Depreciation

44.25 44.13 44.13 35.34 31.66

Other write offs

- - - - -

Adjusted PBT

120.25 103.83 118.84 94.70 67.52

Tax charges

33.10 45.35 32.05 31.52 22.68

Adjusted PAT

87.15 58.48 86.79 63.18 44.84

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

87.15 58.48 86.79 63.18 44.84

Earnigs before appropriation

228.63 175.90 144.86 83.58 69.16

Equity dividend

19.43 12.85 8.04 8.11 8.11

Preference dividend

- - - - -

Dividend tax

-3.29 3.29 1.65 1.57 1.57

Retained earnings

212.49 159.76 135.18 73.90 59.48
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com